Skip to search.
 TSX Up 0.33% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
296.00 Down 10.75(3.50%) 12:53PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:306.75
Open:306.99
Bid:296.06 x 100
Ask:296.53 x 100
1y Target Est:345.68
Beta:1.34
Earnings Date:Jul 21 - Jul 25 (Est.)
Day's Range:286.48 - 308.72
52wk Range:194.66 - 358.89
Volume:1,366,786
Avg Vol (3m):1,808,090
Market Cap:69.97B
P/E (ttm):37.90
EPS (ttm):7.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
BIIBDown 3.50%69.97B
PFEDown 0.66%196.05B

Key Statistics

Forward P/E (1 yr):20.91
P/S (ttm):10.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.34
Quarterly EPS Est (Jun-14) :2.72
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback